Issue link: http://osercommunicationsgroup.uberflip.com/i/265897
C h a i n D r u g s t o r e D a i l y 2 1 M o n d a y, A u g u s t 1 2 , 2 0 1 3 CLOUD-BASED PHARMACY CONNECTIVITY SOLUTIONS Over the past 10 years, IVR has become a critical component in delivering 24/7 convenience to patients and prescribers and solid revenue growth to pharmacies. However, the rapidly changing telecom- munications landscape, which has sharply turned away from traditional Public Switched Telephone Network (PSTN) to broadband and VoIP-based telephone services, requires a new approach to IVR technology. Accordingly, TeleManager Technologies developed iRefill™ Connect, its newest suite of pharmacy automation and con- nectivity solutions using TeleManager's patented cloud-based and VoIP platform, to meet the constantly-changing demands of consumers and to keep up with ever- evolving technologies without creating excess costs and burdens for the pharma- cy and its staff. Cloud-based IVR and telecommuni- cation systems can deliver far greater flex- ibility, scalability and cost efficiency than first-generation, on-site, traditional solu- tions. "The Cloud enables pharmacy chains to slash installation and ongoing maintenance costs associated with IVR," according to Paul Kobylevsky, VP of Operations and COO of TeleManager, "and it also gives smaller pharmacies the same access to next-generation IVR as their larger competitors, without the upfront expense and hassle of on-site installation." Moreover, as a centralized cloud-based solution, the iRefill Connect suite of products also gives pharmacies ongoing access to rapidly-evolving IVR functionality without having to worry about the headaches of redeployment or the costs of replacing obsolete hardware. Pharmacies can advance their IVR func- tionality as fast as their business strategy dictates, rather than having to wait for each physical installation to complete its cost lifecycle before advancing to the next. TeleManager offers numerous inno- vative iRefill Connect products: iRefill Voice, iRefill Mobile, iRefill Facebook, iRefill Text, iRefill Web, iRefill Messaging and iRefill Telecom. "By pro- viding important services like prescrip- tion refills via Facebook– along with mobile and text messaging applications, and via interactive web apps– pharma- cies are able to respond to the growing demand from patients for more control over their own healthcare through vari- ous technologies," said Kobylevsky. "This ability to offer broad, two-way communication with patients is a differ- entiator, especially for chain pharmacies in a highly competitive market." iRefill Voice enables pharmacies to quickly deploy all of the proven func- tionality of the well-established Refill TeleManager in-store IVR without the upfront expense of physical hardware installation. Standard features such as visual access to refill orders, voice mes- sages and on-screen reporting to manage operations, as well as advanced features, including extensive outbound calling, surveying and marketing functionality, are all available in an easy to manage cloud-based footprint. iRefill Mobile delivers patient-cen- tric content and important healthcare services, allowing the patients to: create and update their own profile; control their medications and review the neces- sary educational information on them; set up medication alarm servic- es using our winning adher- ence platform; improve compliance using automated refill reminders; communicate with their phar- macy using the push messaging service directy from the app; and use the interac- tive refill ordering module. All of the iRefill Connect applica- tions take advantage of the company's cloud-based patented technologies, which deliver significant cost savings to pharmacies by eliminating the need for pharmacies to buy and maintain their own infrastructure and hardware. This approach also provides better failover and redundancy capabilities. Overall, the truly successful pharma- cies will communicate with patients in the way patients demand. Today, that means providing a number of options for patients, in a growing array of new media and technology channels. TeleManager Technologies is continuing its commit- ment to improving communications between pharmacies and patients. For more information, call 800-600- 0435, e-mail sales@telemanager.com, visit www.telemanager.com or stop by booth 3216. CRUNCHIES ADDS TO GRAB-N-GO FRUIT LINE, EXPANDS VEGGIES Been waiting to hear exciting health food product news through the grapevine? If so, Crunchies ® – the leading producer of all-natural freeze-dried vegetable and fruit snacks in the country – has a tasty announcement: the addition this June of all-natural Red Grapes to its popular Grab-n-Go 1.5-ounce fruit line. Delectable grapes, long a favorite of young and old alike, are now easily packed into even the fullest backpack, whether for school, play, sports or a hike. In addition, Crunchies in June will introduce five new veggies to its Grab-n- Go family: Buttered Sweet Corn, BBQ Roasted Veggies, Sugar Snap Peas, Buttered Power Veggies, and Herbed Spiced Power Veggies. Both Power Veggies feature flavorful blends of corn, edamame, peas and carrots seasoned with natural spices, flavorings and sea salt. With such a palette-pleasing variety sure to match every taste, consumers can now crunch all their favorite vegetables in sin- gle snacks every bit as healthy and con- venient as they are delicious. Like all Crunchies' fruit products, Red Grapes Grab-n-Go is made in the U.S. through a unique freeze-drying process in which individually frozen grapes are placed in a refrigerated vacu- um chamber that removes up to 97 per- cent of the moisture. This special process gives Crunchies their namesake crunchy texture and allows them to retain a high percentage of the nutritious enzymes that are invariably lost through traditional heat drying. Veggie Crunchies are not only incredibly wholesome, but are also rich in fiber, protein and isoflavones. Each delicious flavor contains relatively little fat while providing a nutritional burst of energy that's available anywhere, anytime, thanks to Crunchies' convenient re-seal- able pouches. "The tasty new additions to Crunchies' best-selling Grab-n-Go lines represent an integral facet of the compa- ny's 2013 product expansion," said Jim Lacey, President and CEO of Crunchies Food Company. Having enjoyed a tripling of sales nationwide over the past year, Crunchies is in the midst of its greatest period of growth to date in terms of new product launches, expanded distribution, new strategic alliances and widespread event sponsorships. About Crunchies Food Company, LLC Founded in 2006, Crunchies Food Company, LLC has created a nationally distributed line of freeze-dried fruits and vegetables that are redefining healthy snacking for the 21st century. Free of additives, chemicals, preservatives or unhealthy ingredients, Crunchies are "Nature's Ultimate Snack Food." For more information, visit www.crunchiesfood.com or call 888-997- 1866. Visit Crunchies booth 3045 to try the new grape. ZYDUS CADILA HEALTHCARE, ZYDUS PHARMACEUTICALS (USA) INC. LOOK FORWARD TO THE FUTURE Zydus Pharmaceuticals (USA) Inc. is the United States generic drug division of a larger, India-based company known as Zydus Cadila Healthcare. Zydus Cadila is a global, fully integrated phar- maceutical company with a presence in 50 countries and is committed to grow- ing its foot print both around the world and in the U.S. Zydus Cadila has worked to achieve this goal through acquisitions and organ- ic growth. Over the last seven years, it has acquired companies in India, France, Japan, Brazil, Spain, South Africa, and the U.S. Throughout the world, Zydus is focused on providing outstanding cus- tomer service, along with high-quality, affordable products. While Zydus Cadila continues to focus on the domestic market in India, it is growing rapidly in key regulated generic markets, such as the U.S., Europe, Japan, and Latin America. As the fifth largest pharmaceutical compa- ny in India, Zydus is well-positioned to meet the needs of the growing generic pharmaceutical marketplace and is forg- ing relationships as a strategic contract manufacturer. A never-ending commit- ment to innovation and a focus on build- ing a strong pipeline that will deliver the most value to both the company as well as customers set Zydus apart from other generic firms. Zydus Cadila takes pride in its man- ufacturing and development history. Its FDA-approved Moraiya plant is India's largest finished dosage plant under one roof, spanning 40 acres. Its modular design allows for rapid expansion to meet additional capacity needs for the ever-growing global demand for generic pharma- ceuticals. Zydus has received U.S. FDA approval for its Baddi plant and has filed its first product from its newest plant located in the SEZ (Special Economic Zone) within Ahmedabad. Combined, these three plants will give Zydus an annual capacity of over 20 billion pills/capsules within the next three years. The purchase of Nesher Pharmaceuticals based in St. Louis, Mo., has given Zydus manufactur- ing capabilities within the U.S. and the ability to manufacture and supply con- trolled substances in the U.S. market. The breadth of the company's prod- uct form capabilities is a continuous focus for the Zydus Cadila organization. Within the U.S., Zydus currently pro- vides tablets, hard and soft gelatin cap- sules, suspensions, injectables, and will be introducing nasal products in the near future. Through its pipeline, Zydus is focused on expanding these capabilities into other areas such as parenterals, metered dose inhalers, and transdermal patches. Zydus has also completed manu- facturing sites for bio- logics, vaccines, and oncology products. Chief Executive Officer of the U.S. division, Joe Renner, envisions a U.S. generic marketplace where manufactur- ers and customers come together in the sourcing of generic products earlier on in the continuum of product manage- ment in order to maximize the risk- reward profiles and deliver maximum value to all parties involved. With major support from its parent company, Zydus Pharmaceuticals (USA) Inc. con- tinues to grow by delivering products to the U.S. marketplace. Visit Zydus Pharmaceuticals (USA) Inc. at booth 2808 or learn more about the company through its website at www.zydususa.com.